XBiotech Inc
XBIT
Get informed when a big investor buys or sells
+ FollowMarket Cap$73.78M
Close$
$4.12
72.3% upside
Current Fair Value
72.3% upsideUndervalued by 72.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $73.78 Million |
|---|---|
| Enterprise Value | $-41,571,691.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.49 |
| Beta | 0.86 |
| Outstanding Shares | 30,487,731 |
Return
| Return on Equity | -29.75% |
|---|---|
| Return on Assets | -28.72% |
| Return on Invested Capital | -31.91% |
Valuation & Multiples
| P/E Ratio | -1.84 |
|---|---|
| PEG | 3.72 |
| Price to Sales | - |
| Price to Book Ratio | 0.6 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.95 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$0.03
Average shareholder expectationRevenue Estimate
$7.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 21,100▲ 14.67% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 6.54%▼ 0.99% |
|---|---|
| Total Invested | $4.68M▼ 14.62% |
| Investors Holding | 38▼ 2.00% |
ESG Score
No data
About XBiotech Inc
CEO: John Simard